Cite
APA Citation
Henderson, R. D., Agosti, J. M., McCombe, P. A., Thorpe, K., Heggie, S., Heshmat, S., Appleby, M. W., Ziegelaar, B. W., Crowe, D. T., & Redlich, G. L. (2021). phase 1b dose-escalation, safety, and pharmacokinetic study of IC14, a monoclonal antibody against CD14, for the treatment of amyotrophic lateral sclerosis. Medicine, 100(42), . http://access.bl.uk/ark:/81055/vdc_100174360133.0x000024